MARKET

ANIX

ANIX

Anixa Biosciences Inc
NASDAQ
3.230
+0.100
+3.19%
After Hours: 3.330 +0.1 +3.10% 19:45 03/27 EDT
OPEN
3.130
PREV CLOSE
3.130
HIGH
3.300
LOW
3.130
VOLUME
52.79K
TURNOVER
0
52 WEEK HIGH
6.45
52 WEEK LOW
2.750
MARKET CAP
103.04M
P/E (TTM)
-9.3596
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ANIX last week (0318-0322)?
Weekly Report · 3d ago
Anixa Biosciences Stockholders Affirm Confidence and Oversight
TipRanks · 5d ago
Anixa Biosciences Price Target Maintained With a $12.00/Share by HC Wainwright & Co.
Dow Jones · 03/21 10:43
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
Benzinga · 03/21 10:33
Anixa Biosciences: A Buy Rating on Strong Financials and Promising Oncology Advances
TipRanks · 03/21 10:17
Weekly Report: what happened at ANIX last week (0311-0315)?
Weekly Report · 03/18 10:13
Recap: Anixa Biosciences Q1 Earnings
Anixa Biosciences reported its Q1 earnings on March 12. The company missed estimates by -11.0% and missed revenue by $0.1. Anixa will report its earnings on Tuesday, March 12 at 5:00 p.m.
Benzinga · 03/12 21:45
Weekly Report: what happened at ANIX last week (0304-0308)?
Weekly Report · 03/11 10:11
More
About ANIX
Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well as other forms of breast cancer and the development of a preventative vaccine against ovarian cancer. Its therapeutics programs include the development of a chimeric endocrine receptor T cell therapy, a novel form of chimeric antigen receptor T cell (CAR-T) technology, initially focused on treating ovarian cancer, which is being developed by its subsidiary, Certainty Therapeutics, Inc. (Certainty). Certainty is developing immuno-therapy drugs against cancer. The Company’s vaccine portfolio consists of technology focused on the immunization against specific retired proteins.

Webull offers Anixa Biosciences Inc stock information, including NASDAQ: ANIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIX stock methods without spending real money on the virtual paper trading platform.